Do you want to change careers? Are you absolutely sure?
From my own career change to the stories I hear from my clients and workshop students, often we think we want to change careers when the problem is our work environment instead. If you find yourself stuck, unsure what to do next, or t
Sears Holdings Corp. (Nasdaq: SHLD), a company that has been around for more than 130 years, was at one time the largest mail-order retailer to rural America. In 1931 it accounted for more than 53.4% of total mail-order sales. It survived through not only one but two world wars and the Great Depression.
In its early years, Sears transformed the middle class by giving it access to products....More>>>
The number of people working or looking for work in the U.S. is near a four-decade low, and some experts believe that the opioid epidemic has played a key role in keeping a lid on participation.
According to Jeff Korzenik, chief investment adviser at Fifth Third Bank, the abuse of painkillers that has gripped the nation could be at the heart of a weaker reading of labor-force participation....More>>>
Uranium has been back in the news lately, not only due to its relationship with geopolitical maneuvering concerning nuclear weapons, but also as a necessary commodity in the global quest for clean, renewable energy.
The United States is the world’s largest producer of nuclear power, accounting for more than 30% of worldwide nuclear generation of electricity. While....More>>>
Enphase Energy (NASDAQ:ENPH) shot up 1.2% during mid-day trading on Thursday . The company traded as high as $6.04 and last traded at $5.65. 83,628 shares traded hands during mid-day trading, a decline of 95% from the average session volume of 1,595,823 shares. The stock had previously closed at $5.72.
Several research analysts have weighed in on ENPH shares. HC Wainwright started coverage....More>>>
President Trump called for tariffs on U.S. steel and aluminum imports that could hurt corporations as well as consumers. Such tariffs also stirred fears of a trade dispute between the United States and China. This in turn propelled Wall Street’s fear gauge index above its historic average and dragged the broader markets down.
Boston, MA, based Investment company North Tide Capital, Llc buys Impax Laboratories, Allergan PLC, Accuray, sells Community Health Systems, Valeant Pharmaceuticals International, Mylan NV, Perrigo Co PLC, Select Medical Holdings during the 3-months ended 2016-12-31, according to the most recent filings of the investment company, North Tide Capital, Llc. As of 2016-12-31, North Tide Capital, Llc....More>>>
Stocks made gains on Thursday after the Labor Department reported that consumer prices rose less than expected in April, easing worries about inflation. TheDow Jones Industrial Average (DJINDICES:^DJI)rose nearly 200 points and theS&P 500 (SNPINDEX:^GSPC)added almost a percentage point.
Today’s stock market
Index Percentage Change Point Change
Source: ThinkstockJanuary 5, 2018: The S&P 500 closed up 0.7% at 2,742.70. The DJIA closed up 0.9% at 25,291.67. Separately, the Nasdaq was up 0.8% at 7,136.56.
Friday proved to be yet another positive day for the broad U.S. markets, with all major exchanges hitting a new record high. With the first week of 2018 in the books, it seems that the markets can only go up from here with the....More>>>
Brokerages expect Bed Bath & Beyond Inc. (NASDAQ:BBBY) to post earnings per share (EPS) of $0.48 for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have issued estimates for Bed Bath & Beyond’s earnings. The lowest EPS estimate is $0.43 and the highe
MorphoSys AG (MOR) is a recent addition to the Nasdaq, having raked in close to $208 million in their April IPO when 2,075,000 new ordinary shares in the form of 8,300,000 American Depositary Shares were priced at $25.04 per ADS.
The fact that they were able to raise more than the origina
Equities research analysts forecast that Agios Pharmaceuticals (NASDAQ:AGIO) will announce earnings per share (EPS) of ($1.66) for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for Agios Pharmaceuticals’ earnings, with the lowest EPS e